Specifically, the study found that in patients with PAH, the levels of IDO-TMs (indoleamine 2,3-dioxygenase metabolites), as opposed to those of tryptophan hydroxylase metabolites, were elevated and exhibited a strong correlation with right ventricular–pulmonary vasculature dysfunction [37]. This evidence concerns the gene IDO1 and pulmonary arterial hypertension.